Cite
Metformin Use and Clinical Outcomes Among Patients With Diabetes Mellitus With or Without Heart Failure or Kidney Dysfunction: Observations From the SAVOR-TIMI 53 Trial.
MLA
Bergmark, Brian A., et al. “Metformin Use and Clinical Outcomes Among Patients With Diabetes Mellitus With or Without Heart Failure or Kidney Dysfunction: Observations From the SAVOR-TIMI 53 Trial.” Circulation, vol. 140, no. 12, Sept. 2019, pp. 1004–14. EBSCOhost, https://doi.org/10.1161/CIRCULATIONAHA.119.040144.
APA
Bergmark, B. A., Bhatt, D. L., McGuire, D. K., Cahn, A., Mosenzon, O., Steg, P. G., Im, K., Kanevsky, E., Gurmu, Y., Raz, I., Braunwald, E., Scirica, B. M., & SAVOR-TIMI 53 Steering Committee and Investigators. (2019). Metformin Use and Clinical Outcomes Among Patients With Diabetes Mellitus With or Without Heart Failure or Kidney Dysfunction: Observations From the SAVOR-TIMI 53 Trial. Circulation, 140(12), 1004–1014. https://doi.org/10.1161/CIRCULATIONAHA.119.040144
Chicago
Bergmark, Brian A., Deepak L. Bhatt, Darren K. McGuire, Avivit Cahn, Ofri Mosenzon, Ph. Gabriel Steg, KyungAh Im, et al. 2019. “Metformin Use and Clinical Outcomes Among Patients With Diabetes Mellitus With or Without Heart Failure or Kidney Dysfunction: Observations From the SAVOR-TIMI 53 Trial.” Circulation 140 (12): 1004–14. doi:10.1161/CIRCULATIONAHA.119.040144.